Skip to main content
logo
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
449.20
+2.00 (0.45%)
At close: May 11, 2026

HKG:6990 Revenue

In the year 2025, Sichuan Kelun-Biotech Biopharmaceutical had annual revenue of 2.06B CNY with 6.46% growth. Sichuan Kelun-Biotech Biopharmaceutical had revenue of 1.11B in the half year ending December 31, 2025, with 124.06% growth.

Revenue
2.06B CNY
Revenue Growth
+6.46%
P/S Ratio
45.54
Revenue / Employee
1.01M CNY
Employees
2,045
Market Cap
104.28B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.06B124.88M6.46%
Dec 31, 20241.93B392.55M25.48%
Dec 31, 20231.54B736.56M91.62%
Dec 31, 2022803.93M771.61M2,387.26%
Dec 31, 202132.32M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BeOne Medicines AG45.00B
Sino Biopharmaceutical35.43B
WuXi Biologics24.25B
3SBio19.69B
Innovent Biologics14.51B
Genscript Biotech7.47B
Shanghai Henlius Biotech7.42B
RemeGen3.84B
Revenue Rankings

Sichuan Kelun-Biotech Biopharmaceutical News

More News